期刊
CURRENT MEDICINAL CHEMISTRY
卷 17, 期 14, 页码 1468-1486出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/092986710790980005
关键词
Cannabinoid; GPCR; endocannabinoid; anandamide; 2-AG; molecular dynamics; QSAR; mutation
资金
- National Institute on Drug Abuse [RO1 DA003934, KO5 DA021358]
- NATIONAL INSTITUTE ON DRUG ABUSE [K05DA021358, R01DA003934] Funding Source: NIH RePORTER
The cannabinoid CB1 and CB2 receptors are Class A G protein-coupled receptors (GPCRs). While many Class A GPCRs have endogenous ligands that are hydrophilic cations (e. g., the serotonin and dopamine receptors), the cannabinoid receptors have neutral, highly lipophilic ligands derived from the fatty acid, arachidonic acid. The most well-studied of these are N-arachidonoylethanolamine (anandamide, AEA) and sn-2-arachidonoylglycerol (2-AG). This review focuses on the experimental and computational studies that have been used to probe the nature of endocannabinoid interaction with the cannabinoid receptors. These studies include mutation, SAR and NMR studies, as well as, QSAR, docking and molecular dynamics simulations. Gaps in our knowledge are identified. The review begins more generally, however, by discussing the entire endocannabinoid system, of which the cannabinoid receptors are part. For in order to understand endocannabinoid action, one needs an appreciation for the environments for which these ligands have been designed and the conformational changes these ligands must undergo in order to act on the cannabinoid receptors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据